BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

854 related articles for article (PubMed ID: 19159684)

  • 1. Evaluation of the nonparametric estimation method in NONMEM VI.
    Savic RM; Kjellsson MC; Karlsson MO
    Eur J Pharm Sci; 2009 Apr; 37(1):27-35. PubMed ID: 19159684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parametric and nonparametric population methods: their comparative performance in analysing a clinical dataset and two Monte Carlo simulation studies.
    Bustad A; Terziivanov D; Leary R; Port R; Schumitzky A; Jelliffe R
    Clin Pharmacokinet; 2006; 45(4):365-83. PubMed ID: 16584284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fisher information matrix for nonlinear mixed effects multiple response models: evaluation of the appropriateness of the first order linearization using a pharmacokinetic/pharmacodynamic model.
    Bazzoli C; Retout S; Mentré F
    Stat Med; 2009 Jun; 28(14):1940-56. PubMed ID: 19266541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the nonparametric estimation method in NONMEM VI: application to real data.
    Baverel PG; Savic RM; Wilkins JJ; Karlsson MO
    J Pharmacokinet Pharmacodyn; 2009 Aug; 36(4):297-315. PubMed ID: 19572188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The back-step method--method for obtaining unbiased population parameter estimates for ordered categorical data.
    Kjellsson MC; Jönsson S; Karlsson MO
    AAPS J; 2004 Aug; 6(3):e19. PubMed ID: 15760104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Considerations in analyzing single-trough concentrations using mixed-effects modeling.
    Booth BP; Gobburu JV
    J Clin Pharmacol; 2003 Dec; 43(12):1307-15. PubMed ID: 14615466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous versus sequential pharmacokinetic-pharmacodynamic population analysis using an iterative two-stage Bayesian technique.
    Proost JH; Schiere S; Eleveld DJ; Wierda JM
    Biopharm Drug Dispos; 2007 Nov; 28(8):455-73. PubMed ID: 17847121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of different population pharmacokinetic algorithms.
    Colucci P; Grenier J; Yue CS; Turgeon J; Ducharme MP
    Ther Drug Monit; 2011 Oct; 33(5):583-91. PubMed ID: 21912327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance comparison of first-order conditional estimation with interaction and Bayesian estimation methods for estimating the population parameters and its distribution from data sets with a low number of subjects.
    Pradhan S; Song B; Lee J; Chae JW; Kim KI; Back HM; Han N; Kwon KI; Yun HY
    BMC Med Res Methodol; 2017 Dec; 17(1):154. PubMed ID: 29191177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two bootstrapping routines for obtaining imprecision estimates for nonparametric parameter distributions in nonlinear mixed effects models.
    Baverel PG; Savic RM; Karlsson MO
    J Pharmacokinet Pharmacodyn; 2011 Feb; 38(1):63-82. PubMed ID: 21076858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonparametric estimation of ROC curves in the absence of a gold standard.
    Zhou XH; Castelluccio P; Zhou C
    Biometrics; 2005 Jun; 61(2):600-9. PubMed ID: 16011710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction discrepancies for the evaluation of nonlinear mixed-effects models.
    Mentré F; Escolano S
    J Pharmacokinet Pharmacodyn; 2006 Jun; 33(3):345-67. PubMed ID: 16284919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic parameters estimation using adaptive Bayesian P-splines models.
    Jullion A; Lambert P; Beck B; Vandenhende F
    Pharm Stat; 2009; 8(2):98-112. PubMed ID: 18481279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Metropolis Monte Carlo implementation of bayesian time-domain parameter estimation: application to coupling constant estimation from antiphase multiplets.
    Andrec M; Prestegard JH
    J Magn Reson; 1998 Feb; 130(2):217-32. PubMed ID: 9500892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Approaches to handling pharmacodynamic baseline responses.
    Dansirikul C; Silber HE; Karlsson MO
    J Pharmacokinet Pharmacodyn; 2008 Jun; 35(3):269-83. PubMed ID: 18446428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Robust parameter estimation of intensity distributions for brain magnetic resonance images.
    Schroeter P; Vesin JM; Langenberger T; Meuli R
    IEEE Trans Med Imaging; 1998 Apr; 17(2):172-86. PubMed ID: 9688150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The bayesian bias correction method of the first-order approximation of nonlinear mixed-effects models for population pharmacokinetics.
    Funatogawa T; Funatogawa I
    J Biopharm Stat; 2007; 17(3):381-92. PubMed ID: 17479388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of model choices for the Continual Reassessment Method in phase I cancer trials.
    Paoletti X; Kramar A
    Stat Med; 2009 Oct; 28(24):3012-28. PubMed ID: 19672839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bootstrapping the estimated latent distribution of the two-parameter latent trait model.
    Knott M; Tzamourani P
    Br J Math Stat Psychol; 2007 May; 60(Pt 1):175-91. PubMed ID: 17535586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statistical models for autocorrelated count data.
    Nelson KP; Leroux BG
    Stat Med; 2006 Apr; 25(8):1413-30. PubMed ID: 16196078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.